161 related articles for article (PubMed ID: 30277395)
1. Identification and Characterization of DNA Aptamers Specific for Phosphorylation Epitopes of Tau Protein.
Teng IT; Li X; Yadikar HA; Yang Z; Li L; Lyu Y; Pan X; Wang KK; Tan W
J Am Chem Soc; 2018 Oct; 140(43):14314-14323. PubMed ID: 30277395
[TBL] [Abstract][Full Text] [Related]
2. Functional Selection of Tau Oligomerization-Inhibiting Aptamers.
Wang B; Pan X; Teng IT; Li X; Kobeissy F; Wu ZY; Zhu J; Cai G; Yan H; Yan X; Liang M; Yu F; Lu J; Yang Z; Biondi E; Haskins W; Cao YC; Benner SA; Tan W; Wang KK
Angew Chem Int Ed Engl; 2024 Apr; 63(18):e202402007. PubMed ID: 38407551
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory RNA Aptamers of Tau Oligomerization and Their Neuroprotective Roles against Proteotoxic Stress.
Kim JH; Kim E; Choi WH; Lee J; Lee JH; Lee H; Kim DE; Suh YH; Lee MJ
Mol Pharm; 2016 Jun; 13(6):2039-48. PubMed ID: 27120117
[TBL] [Abstract][Full Text] [Related]
4. A dip-and-read optical aptasensor for detection of tau protein.
Ziu I; Laryea ET; Alashkar F; Wu CG; Martic S
Anal Bioanal Chem; 2020 Feb; 412(5):1193-1201. PubMed ID: 31900535
[TBL] [Abstract][Full Text] [Related]
5. Phosphorylation-dependent epitopes of neurofilament antibodies on tau protein and relationship with Alzheimer tau.
Lichtenberg-Kraag B; Mandelkow EM; Biernat J; Steiner B; Schröter C; Gustke N; Meyer HE; Mandelkow E
Proc Natl Acad Sci U S A; 1992 Jun; 89(12):5384-8. PubMed ID: 1376918
[TBL] [Abstract][Full Text] [Related]
6. Regulation of the phosphorylation state and microtubule-binding activity of Tau by protein phosphatase 2A.
Sontag E; Nunbhakdi-Craig V; Lee G; Bloom GS; Mumby MC
Neuron; 1996 Dec; 17(6):1201-7. PubMed ID: 8982166
[TBL] [Abstract][Full Text] [Related]
7. Designing antibodies against LRRK2-targeted tau epitopes.
Hamm M; Ladd TB; Levites Y; Golde TE; Giasson BI; Lewis J
PLoS One; 2018; 13(9):e0204367. PubMed ID: 30261006
[TBL] [Abstract][Full Text] [Related]
8. Methods for Improving Aptamer Binding Affinity.
Hasegawa H; Savory N; Abe K; Ikebukuro K
Molecules; 2016 Mar; 21(4):421. PubMed ID: 27043498
[TBL] [Abstract][Full Text] [Related]
9. Phosphorylation of tau at both Thr 231 and Ser 262 is required for maximal inhibition of its binding to microtubules.
Sengupta A; Kabat J; Novak M; Wu Q; Grundke-Iqbal I; Iqbal K
Arch Biochem Biophys; 1998 Sep; 357(2):299-309. PubMed ID: 9735171
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of therapeutic potential of a naturally occurring human antibody targeting a phosphorylated Ser
van Ameijde J; Crespo R; Janson R; Juraszek J; Siregar B; Verveen H; Sprengers I; Nahar T; Hoozemans JJ; Steinbacher S; Willems R; Delbroek L; Borgers M; Dockx K; Van Kolen K; Mercken M; Pascual G; Koudstaal W; Apetri A
Acta Neuropathol Commun; 2018 Jul; 6(1):59. PubMed ID: 30001207
[TBL] [Abstract][Full Text] [Related]
11. Epitope mapping of monoclonal antibodies to the paired helical filaments of Alzheimer's disease: identification of phosphorylation sites in tau protein.
Goedert M; Jakes R; Crowther RA; Cohen P; Vanmechelen E; Vandermeeren M; Cras P
Biochem J; 1994 Aug; 301 ( Pt 3)(Pt 3):871-7. PubMed ID: 7519852
[TBL] [Abstract][Full Text] [Related]
12. Tau Fibril Formation in Cultured Cells Compatible with a Mouse Model of Tauopathy.
Matsumoto G; Matsumoto K; Kimura T; Suhara T; Higuchi M; Sahara N; Mori N
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29772786
[TBL] [Abstract][Full Text] [Related]
13. Direct interaction of soluble human recombinant tau protein with Abeta 1-42 results in tau aggregation and hyperphosphorylation by tau protein kinase II.
Rank KB; Pauley AM; Bhattacharya K; Wang Z; Evans DB; Fleck TJ; Johnston JA; Sharma SK
FEBS Lett; 2002 Mar; 514(2-3):263-8. PubMed ID: 11943163
[TBL] [Abstract][Full Text] [Related]
14. Novel Phospho-Tau Monoclonal Antibody Generated Using a Liposomal Vaccine, with Enhanced Recognition of a Conformational Tauopathy Epitope.
Theunis C; Adolfsson O; Crespo-Biel N; Piorkowska K; Pihlgren M; Hickman DT; Gafner V; Borghgraef P; Devijver H; Pfeifer A; Van Leuven F; Muhs A
J Alzheimers Dis; 2017; 56(2):585-599. PubMed ID: 28035925
[TBL] [Abstract][Full Text] [Related]
15. [Screening and characterization of DNA aptamers with hTNF-alpha binding and neutralizing activity].
Guo KT; Yan XR; Huang GJ; Xu CX; Chai YS; Zhang ZQ
Sheng Wu Gong Cheng Xue Bao; 2003 Nov; 19(6):730-3. PubMed ID: 15971588
[TBL] [Abstract][Full Text] [Related]
16. Neuropathogenic role of adenylate kinase-1 in Aβ-mediated tau phosphorylation via AMPK and GSK3β.
Park H; Kam TI; Kim Y; Choi H; Gwon Y; Kim C; Koh JY; Jung YK
Hum Mol Genet; 2012 Jun; 21(12):2725-37. PubMed ID: 22419736
[TBL] [Abstract][Full Text] [Related]
17. Methods for selection of aptamers to protein targets.
Kulbachinskiy AV
Biochemistry (Mosc); 2007 Dec; 72(13):1505-18. PubMed ID: 18282139
[TBL] [Abstract][Full Text] [Related]
18. Increased O-GlcNAcylation reduces pathological tau without affecting its normal phosphorylation in a mouse model of tauopathy.
Graham DL; Gray AJ; Joyce JA; Yu D; O'Moore J; Carlson GA; Shearman MS; Dellovade TL; Hering H
Neuropharmacology; 2014 Apr; 79():307-13. PubMed ID: 24326295
[TBL] [Abstract][Full Text] [Related]
19. Generation and characterization of new monoclonal antibodies targeting the PHF1 and AT8 epitopes on human tau.
Strang KH; Goodwin MS; Riffe C; Moore BD; Chakrabarty P; Levites Y; Golde TE; Giasson BI
Acta Neuropathol Commun; 2017 Jul; 5(1):58. PubMed ID: 28760159
[TBL] [Abstract][Full Text] [Related]
20. Alzheimer disease specific phosphoepitopes of Tau interfere with assembly of tubulin but not binding to microtubules.
Amniai L; Barbier P; Sillen A; Wieruszeski JM; Peyrot V; Lippens G; Landrieu I
FASEB J; 2009 Apr; 23(4):1146-52. PubMed ID: 19074508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
